pharmacopeia

Mechanism of action

Sourced from openFDA

Mechanism-of-action class: Neurotransmitter Transporter Interactions.

Indications

Sourced from openFDA
  • Uses For the temporary relief of minor aches and pains of muscles and joints associated with simple backache, arthritis,strains,bruises and sprains

Dosage & administration

Sourced from openFDA

Other Information Store at controlled room temperature 20°- 25°C (68° - 77°F) Close the cap tightly after use

Warnings & precautions

Sourced from openFDA

For external use only Avoid contact with the eyes and mucous membranes If condition worsens, or if symptoms persist for more than 7 days or clear up and occur again within a few days, discontinue use of this product and consult a doctor. Do not apply to wounds or damaged skin. Do not bandage tightly. Do not use with a heating pad or on wounds, damaged, broken (open) or irritated skin. Discontinue use if excessive irritation of skin develops. If pregnant or breast feeding, ask a health professional before use. A temporary burning sensation may occur upon application, but generally disappears in a few days Keep this and all drugs out of the reach of children. If swallowed, get medical help or contact a Poison Control Center immediately Directions Adults and children 2 years of age and older: Apply to the affected area not more than 3 to 4 times daily. Children under 2 years of age: consult a doctor. Unless treating hands, wash thoroughly with soap and water immediately after use.

FAERS reports

View JSON
Reference statistics only. FAERS reports are voluntarily submitted and are not incidence rates, safety signals, or causal evidence. Counts reflect reporting volume — how often a reaction was reported, not how often it occurs. For decision-grade use, consult openFDA and the FAERS Public Dashboard directly.
23 total reports matchedLatest report Share = reports listing the reaction ÷ total matched reports. Rows can sum to >100% because a single report often lists multiple reactions.
  1. 1Immune Thrombocytopenia939%
  2. 2Therapy Non-responder939%
  3. 3Weight Increased939%
  4. 4Off Label Use626%
  5. 5Withdrawal Syndrome522%
  6. 6Dizziness417%
  7. 7Treatment Failure417%
  8. 8Fatigue313%
  9. 9Acute Kidney Injury28.7%
  10. 10Chronic Kidney Disease28.7%
  11. 11Product Use In Unapproved Indication28.7%
  12. 12Renal Failure28.7%
  13. 13Application Site Hypoaesthesia14.3%
  14. 14Application Site Pain14.3%
  15. 15Asthenia14.3%

Clinical trials

View JSON

The 10 most recently updated of 11 ClinicalTrials.gov registrations naming Capsicum Oleoresin as an intervention. Registration is not evidence of efficacy or safety — reference crosswalk only.

Frequently asked questions

How does Capsicum Oleoresin work?
Mechanism-of-action class: Neurotransmitter Transporter Interactions.
What is Capsicum Oleoresin used for?
According to FDA labeling, Capsicum Oleoresin carries indications including: Uses For the temporary relief of minor aches and pains of muscles and joints associated with simple backache, arthritis,strains,bruises and sprains. This is a reference summary of labeled uses, not medical advice or a treatment recommendation.
What class of drug is Capsicum Oleoresin?
Capsicum Oleoresin is classified as Neurotransmitter Transporter Interactions, Decreased Sensory-Somatic Nervous System Organized Electrical Activity, Increased Sensory-Somatic Nervous System Substance P Activity.
Note. Data for capsicum-oleoresin is illustrative MVP content compiled from public sources. pharmacopeia is for educational and informational use only and is not a substitute for professional medical advice.

Search pharmacopeia

Search drugs, classes, and ingredients